Article
Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 Jun 2006
Price Ric N, Uhlemann Anne-Catrin, van Vugt Michele, Brockman Al, Hutagalung Robert, Nair Shalini, Nash Denae, Singhasivanon Pratap, Anderson Tim J C, Krishna Sanjeev, White Nicholas J, Nosten François
Abstract excerpt
BACKGROUND: Our study examined the relative contributions of host, pharmacokinetic, and parasitological factors in determining the therapeutic response to artemether-lumefantrine (AL). METHODS: On the northwest border of Thailand, patients with uncomplicated Plasmodium falciparum malaria were enrolled in prospective studies of AL treatment (4- or 6-dose regimens) and followed up for 42 days. Plasma lumefantrine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
